Potential Protective Effect of a Formula Supplemented With Fermented Matrices on the Risk of Developing Neonatal Sepsis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a multicenter, randomized, double-blind, placebo controlled trial, with parallel groups and reference group. The aim of the study was to evaluate the hypothesis that an immunonutritional strategy, based on use of Lactobacillus paracasei CBA L74-fermented formula, prevents or limits the development of late-onset-sepsis in preterm infants.
Epistemonikos ID: 70f60b11da0a861f1f24891ab566b50a1b2d3a98
First added on: May 08, 2024